星空体育官方入口网站网址大全-登录入口官网

#标准治疗#

60篇内容 | 1408人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2192096, encodeId=422c2192096ca, content=<a href='/topic/show?id=ec5a1120564b' target=_blank style='color:#2F92EE;'>#心衰体重远程监测#</a> <a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Eur J Heart Fail：心衰体重远程监测与标准治疗对比, objectType=article, longId=816459, objectId=9fa181645956, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240308/1709882460966_1739456.jpg, objectUrl=/article/show_article.do?id=9fa181645956, replyNumber=0, likeNumber=38, createdTime=2024-03-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fa181645956, moduleTitle=Eur J Heart Fail：心衰体重远程监测与标准治疗对比, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9fa181645956)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1948283, encodeId=86701948283f1, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Stroke：急性缺血性卒中患者高血糖强化治疗与标准治疗比较, objectType=article, longId=725593, objectId=5ee6e25593fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ee6e25593fe, replyNumber=0, likeNumber=70, createdTime=2022-05-11, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ee6e25593fe, moduleTitle=Stroke：急性缺血性卒中患者高血糖强化治疗与标准治疗比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5ee6e25593fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948281, encodeId=c005194828158, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=NEJM：侵袭性B细胞淋巴瘤的Tisagenlecleucel或标准治疗比较, objectType=article, longId=298991, objectId=961f298991d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=961f298991d8, replyNumber=0, likeNumber=51, createdTime=2022-04-06, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=961f298991d8, moduleTitle=NEJM：侵袭性B细胞淋巴瘤的Tisagenlecleucel或标准治疗比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=961f298991d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948284, encodeId=77641948284f9, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Kidney Int：在标准治疗中加入贝利单抗可以降低狼疮肾炎发作和eGFR下降的风险, objectType=article, longId=736854, objectId=0bf6e36854f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bf6e36854f0, replyNumber=0, likeNumber=66, createdTime=2023-06-01, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bf6e36854f0, moduleTitle=Kidney Int：在标准治疗中加入贝利单抗可以降低狼疮肾炎发作和eGFR下降的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0bf6e36854f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948282, encodeId=3d62194828256, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Clin Infect Dis：大剂量利福平联合或不联合左氧氟沙星与标准治疗儿童结核性脑膜炎的随机临床试验, objectType=article, longId=723651, objectId=ef06e2365156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef06e2365156, replyNumber=0, likeNumber=61, createdTime=2022-07-31, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef06e2365156, moduleTitle=Clin Infect Dis：大剂量利福平联合或不联合左氧氟沙星与标准治疗儿童结核性脑膜炎的随机临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ef06e2365156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948280, encodeId=4e721948280f8, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗, objectType=article, longId=293179, objectId=48b22931e963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48b22931e963, replyNumber=0, likeNumber=84, createdTime=2022-05-06, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48b22931e963, moduleTitle=N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=48b22931e963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948279, encodeId=2c5119482e9f9, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Lancet Oncol：CDKI联合氟维司群有望成为激素受体阳性、HER2阴性的晚期乳腺癌的标准治疗方案！, objectType=article, longId=219161, objectId=aee8219161b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aee8219161b7, replyNumber=0, likeNumber=59, createdTime=2022-03-18, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aee8219161b7, moduleTitle=Lancet Oncol：CDKI联合氟维司群有望成为激素受体阳性、HER2阴性的晚期乳腺癌的标准治疗方案！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aee8219161b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948277, encodeId=ca7c19482e722, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=HER2阳性早期乳腺癌的标准治疗选择是什么？, objectType=article, longId=213800, objectId=532c21380055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=532c21380055, replyNumber=0, likeNumber=64, createdTime=2022-01-04, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=532c21380055, moduleTitle=HER2阳性早期乳腺癌的标准治疗选择是什么？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=532c21380055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948278, encodeId=b40619482e819, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！, objectType=article, longId=219153, objectId=574821915388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574821915388, replyNumber=0, likeNumber=65, createdTime=2021-11-12, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574821915388, moduleTitle=Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=574821915388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948274, encodeId=46a019482e4fa, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Circulation：秋水仙碱加入急性冠脉综合征的标准治疗方案会如何影响患者预后？, objectType=article, longId=203529, objectId=9e0b2035297c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e0b2035297c, replyNumber=0, likeNumber=60, createdTime=2021-10-05, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e0b2035297c, moduleTitle=Circulation：秋水仙碱加入急性冠脉综合征的标准治疗方案会如何影响患者预后？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9e0b2035297c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948276, encodeId=f24019482e6be, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, objectType=article, longId=206078, objectId=28d22060e857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d22060e857, replyNumber=0, likeNumber=51, createdTime=2021-07-28, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d22060e857, moduleTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=28d22060e857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948273, encodeId=4a2319482e392, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Nat Med：新辅助免疫疗法可能是某特定结肠癌患者的标准治疗方法, objectType=article, longId=201762, objectId=4ac7201e6234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ac7201e6234, replyNumber=0, likeNumber=63, createdTime=2020-11-07, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ac7201e6234, moduleTitle=Nat Med：新辅助免疫疗法可能是某特定结肠癌患者的标准治疗方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ac7201e6234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948275, encodeId=4a8719482e517, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Lancet haematol：达比加群酯有望替代静脉血栓栓塞儿童患者的标准治疗？, objectType=article, longId=204571, objectId=a2732045e132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2732045e132, replyNumber=0, likeNumber=44, createdTime=2021-06-13, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2732045e132, moduleTitle=Lancet haematol：达比加群酯有望替代静脉血栓栓塞儿童患者的标准治疗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a2732045e132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948272, encodeId=4b7d19482e25c, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Gut：利福平用于预防难治性梭状芽胞杆菌感染的标准治疗后的复发, objectType=article, longId=195056, objectId=cda519505692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda519505692, replyNumber=0, likeNumber=50, createdTime=2021-01-14, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda519505692, moduleTitle=Gut：利福平用于预防难治性梭状芽胞杆菌感染的标准治疗后的复发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cda519505692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948271, encodeId=33bd19482e16c, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=2019 ESMO|ripretinib或可成为经重度治疗的GIST患者的标准治疗, objectType=article, longId=181107, objectId=b30018110e10, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b30018110e10, replyNumber=0, likeNumber=56, createdTime=2020-02-17, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b30018110e10, moduleTitle=2019 ESMO|ripretinib或可成为经重度治疗的GIST患者的标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b30018110e10)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948265, encodeId=1be81948265e2, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Lancet：Daratumumab联合标准治疗方案治疗新发多发性骨髓瘤, objectType=article, longId=167672, objectId=ca1516e672e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1516e672e7, replyNumber=0, likeNumber=65, createdTime=2019-06-14, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1516e672e7, moduleTitle=Lancet：Daratumumab联合标准治疗方案治疗新发多发性骨髓瘤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca1516e672e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948266, encodeId=265719482669f, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=骨靶向药物更佳给药间隔研究，降级方案有望成为骨转移患者标准治疗, objectType=article, longId=168099, objectId=0e89168099d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e89168099d7, replyNumber=0, likeNumber=59, createdTime=2019-10-04, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e89168099d7, moduleTitle=骨靶向药物更佳给药间隔研究，降级方案有望成为骨转移患者标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0e89168099d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948270, encodeId=af3619482e0c6, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=JCC：对使用阿达木单抗治疗的克罗恩病患者进行主动药物监测要比标准治疗效果更好, objectType=article, longId=178607, objectId=99f61e86076b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99f61e86076b, replyNumber=0, likeNumber=72, createdTime=2020-05-02, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99f61e86076b, moduleTitle=JCC：对使用阿达木单抗治疗的克罗恩病患者进行主动药物监测要比标准治疗效果更好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=99f61e86076b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948263, encodeId=f65a194826382, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=JCC：一种预测溃疡性结肠炎患者接受标准治疗无效的生物标志物, objectType=article, longId=157381, objectId=66d615e38176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66d615e38176, replyNumber=0, likeNumber=44, createdTime=2019-02-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66d615e38176, moduleTitle=JCC：一种预测溃疡性结肠炎患者接受标准治疗无效的生物标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=66d615e38176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948268, encodeId=e1341948268d0, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=BRAF、EGFR、MEK，三靶向无化疗方案或成为BRAF V600E突变型mCRC新标准治疗, objectType=article, longId=175233, objectId=c5631e5233ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5631e5233ba, replyNumber=0, likeNumber=61, createdTime=2019-12-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5631e5233ba, moduleTitle=BRAF、EGFR、MEK，三靶向无化疗方案或成为BRAF V600E突变型mCRC新标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c5631e5233ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

标准治疗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#心衰体重远程监测# #标准治疗#

Eur J Heart Fail：心衰体重远程监测与标准治疗对比

2024-03-08

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Stroke：急性缺血性卒中患者高血糖强化治疗与标准治疗比较

2022-05-11

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

NEJM：侵袭性B细胞淋巴瘤的Tisagenlecleucel或标准治疗比较

2022-04-06

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Kidney Int：在标准治疗中加入贝利单抗可以降低狼疮肾炎发作和eGFR下降的风险

2023-06-01

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Clin Infect Dis：大剂量利福平联合或不联合左氧氟沙星与标准治疗儿童结核性脑膜炎的随机临床试验

2022-07-31

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗

2022-05-06

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Lancet Oncol：CDKI联合氟维司群有望成为激素受体阳性、HER2阴性的晚期乳腺癌的标准治疗方案！

2022-03-18

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

HER2阳性早期乳腺癌的标准治疗选择是什么？

2022-01-04

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！

2021-11-12

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Circulation：秋水仙碱加入急性冠脉综合征的标准治疗方案会如何影响患者预后？

2021-10-05

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案

2021-07-28

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Nat Med：新辅助免疫疗法可能是某特定结肠癌患者的标准治疗方法

2020-11-07

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Lancet haematol：达比加群酯有望替代静脉血栓栓塞儿童患者的标准治疗？

2021-06-13

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Gut：利福平用于预防难治性梭状芽胞杆菌感染的标准治疗后的复发

2021-01-14

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

2019 ESMO|ripretinib或可成为经重度治疗的GIST患者的标准治疗

2020-02-17

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

Lancet：Daratumumab联合标准治疗方案治疗新发多发性骨髓瘤

2019-06-14

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

骨靶向药物更佳给药间隔研究，降级方案有望成为骨转移患者标准治疗

2019-10-04

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

JCC：对使用阿达木单抗治疗的克罗恩病患者进行主动药物监测要比标准治疗效果更好

2020-05-02

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

JCC：一种预测溃疡性结肠炎患者接受标准治疗无效的生物标志物

2019-02-07

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

BRAF、EGFR、MEK，三靶向无化疗方案或成为BRAF V600E突变型mCRC新标准治疗

2019-12-29

科室
- - 订阅+
  - 更多科室
工具
服务